This Big Pharma Stock Just Got an Upgrade. Is It Time to Buy?

This Big Pharma Stock Just Got an Upgrade. Is It Time to Buy?

Shares of Eli Lilly (NYSE: LLY) recently ticked higher in response to encouraging words from a Wall Street analyst who follows the pharmaceutical industry. Colin Bristow at UBS, an investment bank, thinks this is the most attractive pharma stock you can buy right now. Is Bristow right about Eli Lilly?